Pip Marks

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand†

Gail Matthews, Anchalee Avihingsanon, Sharon R. Lewin et al. · Hepatology · 2008 · 135 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

Behzad Hajarizadeh, Jason Grebely, Marianne Byrne et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 98 citations · Full text

Pharmacy, Preventive Medicine, Infection Prevention +11

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Evan B. Cunningham, Janaki Amin, Alain H. Litwin et al. · Clinical Infectious Diseases · 2019 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals

Gail Matthews, Eric C. Seaberg, Gregory J. Dore et al. · AIDS · 2009 · 62 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection

Judy Chang, Sunee Sirivichayakul, Anchalee Avihingsanon et al. · Journal of Virology · 2009 · 46 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17